CA
GILD icon

CSM Advisors’s Gilead Sciences GILD Stock Holding History

CSM Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.17M Sell
9,282
-21,980
-70% -$2.9M 0.03% 334
2026
Q1 		$4.36M Buy
31,262
+20,457
+189% +$2.86M 0.11% 217
2025
Q4 		$1.33M Sell
10,805
-4,270
-28% -$519K 0.04% 311
2025
Q3 		$1.67M Sell
15,075
-42,400
-74% -$4.82M 0.05% 312
2025
Q2 		$6.37M Sell
57,475
-780
-1% -$83K 0.19% 131
2025
Q1 		$6.53M Sell
58,255
-750
-1% -$77.4K 0.36% 66
2024
Q4 		$5.45M Sell
59,005
-4,760
-7% -$429K 0.25% 73
2024
Q3 		$5.34M Sell
63,765
-3,200
-5% -$244K 0.35% 77
2024
Q2 		$4.59M Sell
66,965
-1,310
-2% -$87.4K 0.32% 71
2024
Q1 		$5M Sell
68,275
-1,350
-2% -$104K 0.33% 76
2023
Q4 		$5.64M Sell
69,625
-995
-1% -$77.4K 0.41% 71
2023
Q3 		$5.29M Sell
70,620
-2,995
-4% -$230K 0.46% 65
2023
Q2 		$5.67M Sell
73,615
-1,150
-2% -$91.7K 0.43% 69
2023
Q1 		$6.2M Hold
74,765
– – 0.54% 54
2022
Q4 		$6.42M Sell
74,765
-1,960
-3% -$155K 0.61% 49
2022
Q3 		$4.73M Sell
76,725
-20,255
-21% -$1.28M 0.52% 60
2022
Q2 		$6M Sell
96,980
-10
-0% -$619 0.55% 57
2022
Q1 		$5.77M Sell
96,990
-9,400
-9% -$601K 0.39% 68
2021
Q4 		$7.73M Sell
106,390
-3,520
-3% -$242K 0.51% 58
2021
Q3 		$7.68M Hold
109,910
– – 0.57% 52
2021
Q2 		$7.57M Sell
109,910
-5,280
-5% -$353K 0.5% 56
2021
Q1 		$7.45M Buy
+115,190
New +$7.43M 1.05% 40

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

CSM Advisors's GILD Position: Q2 2026 in Review

CSM Advisors reduced its Gilead Sciences (GILD) stake by 70% in Q2 2026, selling an estimated $2.9M and leaving 9,282 shares worth $1.17M. The position accounts for 0.03% of the portfolio, ranked #334.

CSM Advisors first reported a position in GILD in Q1 2021 and has held it in 22 quarters since. The position peaked at $7.73M in Q4 2021. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • CSM Advisors held 9,282 shares of Gilead Sciences worth $1.17M as of Q2 2026.
  • CSM Advisors sold 21,980 Gilead Sciences shares in Q2 2026, an estimated $2.9M.
  • Gilead Sciences made up 0.03% of CSM Advisors's portfolio in Q2 2026, its #334 holding.
  • CSM Advisors first reported a position in Gilead Sciences in Q1 2021 and has held it in 22 quarters since.
  • CSM Advisors's Gilead Sciences position peaked at $7.73M in Q4 2021.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on CSM Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.